Balyasny Asset Management
STJ

Balyasny Asset Management’s St Jude Medical STJ Stock Holding History

Balyasny Asset Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-926,853
Closed -$57.3M – 1704
2015
Q4 		$57.3M Buy
+926,853
New +$58.5M 0.4% 55
2015
Q3 		– Sell
-646,326
Closed -$47.2M – 1551
2015
Q2 		$47.2M Buy
646,326
+27,752
+4% +$2M 0.29% 86
2015
Q1 		$40.5M Buy
618,574
+210,727
+52% +$14M 0.33% 79
2014
Q4 		$26.5M Buy
+407,847
New +$26.3M 0.24% 115
2013
Q4 		– Sell
-185,000
Closed -$9.92M – 722
2013
Q3 		$9.92M Buy
+185,000
New +$9.53M 0.13% 203

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Balyasny Asset Management's STJ Position: Q1 2016 in Review

Balyasny Asset Management sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 926,853 shares — an estimated $57.3M sold.

Balyasny Asset Management first reported a position in STJ in Q3 2013 and held it in 5 quarters. The position peaked at $57.3M in Q4 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • Balyasny Asset Management reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • Balyasny Asset Management sold 926,853 St Jude Medical shares in Q1 2016, an estimated $57.3M.
  • Balyasny Asset Management first reported a position in St Jude Medical in Q3 2013 and held it in 5 quarters.
  • Balyasny Asset Management's St Jude Medical position peaked at $57.3M in Q4 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.